Stocks›Healthcare›GMED

GMED Globus Medical, Inc.

NYSEResearch view

Globus Medical, Inc. operates in the Surgical & Medical Instruments & Apparatus industry.

$76.71−2.70%

Oct 16 close · 1D EOD · Databento

HealthcareSurgical & Medical Instruments & ApparatusLarge-capSEC EDGAR FY 2025-12-31

On the WireNo stories on GMED yet. Follow the company and the next one lands in Following.

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 6, 2025 and Nov 5, 2024, after the close.

Last report

Aug 6, 2026+1.57%

after the close

Last 4, next close

median 4.62% either way

up 3 of 4

Every report since 2023 →Earnings calendar →

DateEventSourceNext close

Aug 6Earnings release, after the close · 8-KSEC EDGARSEC EDGAR ↗+1.57%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

17 big days in a year, and what we hold on each

A big day is a close more than 3.72% from the one before, three times GMED’s median day (1.24%). On 3 of the 17, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±3.72%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayGMEDWhat we hold that dayGroup (median of 4) · each

1 Nov 7, 2025+35.94%
Resultsgroup +0.6%, did not move with it
1Nov 7, 2025+35.94%
ResultsFirst close after the Nov 6 results filing
+0.6% did not move with itBSX +1.0 · SYK +0.6 · MMM +0.6 · BDX +0.3
2 Nov 21, 2025+4.55%
Before our storiesgroup +1.9%, did not move with it
2Nov 21, 2025+4.55%
Before our stories
+1.9% did not move with itSYK +2.2 · MMM +2.1 · BDX +1.7 · BSX +0.3
3 Jan 8, 2026+4.51%
Resultsgroup +0.5%, did not move with it
3Jan 8, 2026+4.51%
ResultsFirst close after the Jan 7 results filing
+0.5% did not move with itMMM +1.4 · BDX +1.2 · SYK −0.1 · BSX −0.3
4 Feb 25, 2026+4.72%
Resultsgroup −0.7%, did not move with it
4Feb 25, 2026+4.72%
ResultsFirst close after the Feb 24 results filing
−0.7% did not move with itSYK +0.7 · MMM −0.6 · BDX −0.8 · BSX −2.2
5 May 7, 2026−4.65%
Before our storiesgroup +0.8%, did not move with it
5May 7, 2026−4.65%
Before our stories
+0.8% did not move with itMMM −1.9 · SYK +0.7 · BSX +1.0 · BDX +5.9
6 May 8, 2026−8.37%
Resultsgroup −2.7%, did not move with it
6May 8, 2026−8.37%
ResultsFirst close after the May 7 results filing
−2.7% did not move with itBSX −4.7 · SYK −3.0 · BDX −2.5 · MMM −0.3
7 May 20, 2026+5.13%
Before our storiesgroup +0.1%, did not move with it
7May 20, 2026+5.13%
Before our stories
+0.1% did not move with itSYK +1.2 · MMM +0.3 · BDX 0.0 · BSX −0.3
8 Jun 9, 2026+5.39%
Before our storiesgroup +1.5%, did not move with it
8Jun 9, 2026+5.39%
Before our stories
+1.5% did not move with itSYK +4.1 · MMM +1.6 · BDX +1.4 · BSX +0.5
9 Jun 15, 2026−3.82%
Nothing on GMEDgroup −0.4%, did not move with it
9Jun 15, 2026−3.82%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
−0.4% did not move with itSYK −1.4 · BDX −0.5 · BSX −0.3 · MMM −0.1
10 Jun 18, 2026+5.05%
Nothing on GMEDgroup +1.3%, did not move with it
10Jun 18, 2026+5.05%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
+1.3% did not move with itSYK +2.2 · BDX +1.7 · MMM +0.9 · BSX +0.8
11 Jun 30, 2026−5.87%
Nothing on GMEDgroup −2.2%, did not move with it
11Jun 30, 2026−5.87%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
−2.2% did not move with itSYK −4.7 · BDX −2.5 · BSX −1.8 · MMM −0.3
12 Jul 1, 2026−3.86%
Nothing on GMEDgroup +0.2%, did not move with it
12Jul 1, 2026−3.86%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
+0.2% did not move with itMMM −1.2 · SYK −0.5 · BSX +0.9 · BDX +1.0
13 Jul 2, 2026+5.48%
Nothing on GMEDgroup +3.8%, moved with GMED
13Jul 2, 2026+5.48%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
+3.8% moved with GMEDBSX +4.8 · SYK +4.2 · BDX +3.4 · MMM +0.3
14 Jul 14, 2026−4.93%
Nothing on GMEDgroup −3.3%, moved with GMED
14Jul 14, 2026−4.93%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
−3.3% moved with GMEDSYK −6.2 · BSX −4.5 · BDX −2.1 · MMM −0.7
15 Jul 17, 2026−4.83%
Nothing on GMEDgroup −1.3%, did not move with it
15Jul 17, 2026−4.83%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
−1.3% did not move with itSYK −3.4 · BSX −1.3 · MMM −1.2 · BDX −1.1
16 Aug 10, 2026+4.61%
Nothing on GMEDgroup +1.8%, did not move with it
16Aug 10, 2026+4.61%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
+1.8% did not move with itBSX +2.3 · SYK +2.0 · BDX +1.6 · MMM −0.5
17 Sep 8, 2026−4.15%
Nothing on GMEDgroup −4.5%, moved with GMED
17Sep 8, 2026−4.15%
Nothing on GMEDNo GMED story, brief or results filing in our record that day
−4.5% moved with GMEDSYK −8.8 · BSX −5.9 · BDX −3.0 · MMM −0.6

A story on the same day is not a cause, and a group move is not proof either. Group: the median of SYK, MMM, BSX and BDX that day, the largest companies in GMED’s SEC industry; “moved with GMED” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). GMED reports after the close, so day 1 is the next close. 3 of 4 times, day 6 ended on the same side as day 1.

Reported Jan 7, 2026

day 1+4.51%day 6+3.70%

Reported Feb 24, 2026

day 1+4.72%day 6−1.55%

Reported May 7, 2026

day 1−8.37%day 6−9.91%

Reported Aug 6, 2026

day 1+1.57%day 6+5.94%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 6 report: −5.39%. Four reports is a small sample.

Every report since 2023 →

Each line is GMED’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$10.3B

Revenue$2.9B+16.70%

Net income$537.9M

EPS, diluted$3.92+422.70%

Operating margin16.3%

Return on equity11.8%

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$10.3B

Enterprise Value$9.8B

Income$537.9M

Sales$2.9B

Book/sh$34.06

Cash/sh$3.92

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio2.74

Current Ratio4.26

Debt/Eq—

EPS (ttm)$3.92

EPS this Y422.7%

EPS past 3/5Y28.4%

Sales past 3/5Y42.2%

EPS Y/Y TTM422.7%

Sales Y/Y TTM16.7%

Shs Outstand134.26M

ROA10.1%

ROE11.8%

ROIC10.5%

Gross Margin—

Oper. Margin16.3%

Profit Margin18.3%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$958.1M

FY21

$1.0B

FY22

$1.6B

FY23

$2.5B

FY24

$2.9B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$958.1M	$1.0B	$1.6B	$2.5B	$2.9B
Gross Profit	$718.9M	$759.1M	$1.0B	—	—
Operating Income	$172.0M	$228.0M	$133.1M	$166.0M	$479.8M
Net Income	$149.2M	$190.2M	$122.9M	$103.0M	$537.9M
Diluted EPS	$1.44	$1.85	$1.07	$0.75	$3.92
Operating Cash Flow	$276.3M	$178.5M	$243.5M	$520.6M	$753.4M
Free Cash Flow	$219.4M	$104.4M	$165.2M	$405.2M	$588.8M

Same industry

GMED against four medical device peers, a year at 100

GMED is up 28.8% in a year. All four did less: 3M (+7.9%), Becton Dickinson (+1.4%), Stryker (−21.3%) and Boston Scientific (−55.3%). Weekly closes, Oct 17, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

GMED +28.8%. 3M +7.9%, Becton Dickinson +1.4%, Stryker −21.3%, Boston Scientific −55.3%. Weekly closes, Oct 17, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in GMED’s SEC industry (Surgical & Medical Instruments & Apparatus) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

SYK$113.0B MMM$85.0B BSX$64.3B BDX$52.2B RMD$34.5B DXCM$32.5B MDLN$29.1B WST$27.0B

Build basket with GMED Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.